HRT was not recommended in cases such as antiphospholipid syndrome, breast cancer without genitourinary symptoms, in those of advanced age or in line with patient choice with patient decision not to take HRT after an individualised risk benefit evaluation. For 26 (9%) patients, only topical ...
The Royal College of Obstetricians and Gynaecologists (RCOG), the British Menopause Society (BMS), and the Faculty of Sexual and Reproductive Healthcare (FSRH) are warning of the risk of unwanted pregnancies and abortions, as well as the physical and mental impact on women and girls. Why the ...
Compared with never use or discontinuation of menopausal hormone therapy after age 65 years, the use of estrogen monotherapy beyond age 65 years was associated with significant risk reductions in mortality (19% or adjusted hazards ratio, 0.81; 95% CI, 0.79-0.82), brea...